Literature DB >> 20043086

ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.

Hae-Young Yong1, In-Young Kim, Jong Suk Kim, Aree Moon.   

Abstract

Overexpression of ErbB2 has been frequently found in mammary carcinoma. We have previously shown that the aberrant activation of H-Ras induces human breast cell invasion and migration. The present study was aimed at investigating the effect of ErbB2 overexpression on H-Ras-induced breast cell invasion and to elucidate the underlying mechanisms. Herein, we show that overexpression of ErbB2 promotes invasive and migratory abilities of H-Ras-activated MCF10A human breast epithelial cells through upregulation of matrix metalloproteinase (MMP)-13 and urokinase-type plasminogen activator (uPA). We also demonstrate that the p38 MAPK is an important signaling molecule in the ErbB2-induced upregulation of MMP-13 and uPA and invasion/migration of H-Ras MCF10A cells overexpressing ErbB2. The present study elucidating the molecular mechanism underlying ErbB2-induced promotion of H-Ras MCF10A cell invasion may provide invaluable information for understanding breast cancer progression and establishing therapeutic interventions for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043086

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

1.  Regulation of Kruppel-like factor 2 (KLF2) in the pathogenesis of intracranial aneurysm induced by hemodynamics.

Authors:  Xi Wu; Jian-Zhong Zhang; Peng-Fei Yang; Qing-Hai Huang; Jian-Min Liu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration.

Authors:  Timo Rath; Julia Stöckle; Martin Roderfeld; Annette Tschuschner; Jürgen Graf; Elke Roeb
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

3.  Actopaxin (α-parvin) phosphorylation is required for matrix degradation and cancer cell invasion.

Authors:  Jeanine Pignatelli; Sara E LaLonde; David P LaLonde; Dominic Clarke; Christopher E Turner
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

Review 4.  Pericellular proteolysis in cancer.

Authors:  Lisa Sevenich; Johanna A Joyce
Journal:  Genes Dev       Date:  2014-11-01       Impact factor: 11.361

5.  TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.

Authors:  Clément Chevalier; Guillaume Collin; Simon Descamps; Heiani Touaitahuata; Valérie Simon; Nicolas Reymond; Laurent Fernandez; Pierre-Emmanuel Milhiet; Virginie Georget; Serge Urbach; Laurence Lasorsa; Béatrice Orsetti; Florence Boissière-Michot; Evelyne Lopez-Crapez; Charles Theillet; Serge Roche; Christine Benistant
Journal:  Nat Commun       Date:  2016-02-22       Impact factor: 14.919

6.  Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma.

Authors:  Xing-Dong Cai; Li Che; Jia-Xin Lin; Shuai Huang; Jiong Li; Xiao-Yan Liu; Xing-Fei Pan; Qin-Qin Wang; Li Chen; Ming-Juan Lin; Zhi-Hong Huang; Hong-Ming Ma; Yi Wu; Sheng-Ming Liu; Yan-Bin Zhou
Journal:  Oncotarget       Date:  2017-06-13

Review 7.  MMP-2 and 9 in Chronic Kidney Disease.

Authors:  Zhengyuan Cheng; Manoj Hang Limbu; Zhi Wang; Jing Liu; Lei Liu; Xiaoyi Zhang; Pingsheng Chen; Bicheng Liu
Journal:  Int J Mol Sci       Date:  2017-04-08       Impact factor: 5.923

8.  High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis.

Authors:  Qilong Liu; Wenfeng Li; Shibin Yang; Zhaoguo Liu
Journal:  Onco Targets Ther       Date:  2018-11-29       Impact factor: 4.147

9.  Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells.

Authors:  Claudia Oyanadel; Christopher Holmes; Evelyn Pardo; Claudio Retamal; Ronan Shaughnessy; Patricio Smith; Priscilla Cortés; Marcela Bravo-Zehnder; Claudia Metz; Teo Feuerhake; Diego Romero; Juan Carlos Roa; Viviana Montecinos; Andrea Soza; Alfonso González
Journal:  Mol Biol Cell       Date:  2018-01-03       Impact factor: 4.138

10.  Screening and identification of small molecule inhibitors of ErbB2-induced invasion.

Authors:  D M Brix; B Rafn; K Bundgaard Clemmensen; S H Andersen; N Ambartsumian; M Jäättelä; T Kallunki
Journal:  Mol Oncol       Date:  2014-07-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.